XFOR X4 Pharmaceuticals, Inc Total Debt to Capital
The X4 Pharmaceuticals (XFOR) price chart demonstrates a total debt-to-equity ratio of 0.47. Business revenues are based on the market launch of mavorixafor, an innovative treatment for WHIM syndrome. The company is currently focusing on independent promotion within US medical centers and distribution partnerships. Leading immunology experts, attracted by large-scale investments in scientific research, are driving this success.
Analytical breakdowns and data insights for company X4 Pharmaceuticals, Inc (XFOR)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:XFOR - X4 Pharmaceuticals, Inc.
This indicator measures the degree of financial leverage by comparing total credit obligations against net assets to assess the stability of the financing structure. Analyzing the total debt-to-equity ratio determines how effectively X4 Pharmaceuticals (XFOR) utilizes borrowed funds to scale its immunological ecosystem and ensure long-term care for a patient base with rare blood pathologies.
Main competitors
Debt to Equity argenx ARGX|Aggregate Debt to Equity BioNTech Inc.|Abivax SA (ABVX) - Total Debt to Capital|All Debt to Shareholders' Equity Ratio ADMA Corp (ADMA)|Total Debt to Capital PTGX (Protagonist Therapeutics)|immunovant.com - Total Debt to Capital|Debt to Equity Kiniksa (KNSA)|GRFS: All Debt to Shareholders' Equity Ratio|ADPT (Adaptive Biotechnologies Corp) - Debt to Equity|Celldex Corp (CLDX) - Total Debt to Equity Ratio|AUPH (Aurinia Pharmaceuticals) - Total Debt to Capital|Total Debt to Capital biocryst.com (BCRX)|Vera Therapeutics (VERA) - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio Dianthus Therapeutics Inc (DNTH)|Total Debt to Capital PHVS|AbCellera - Total Debt to Capital Coefficient|TRML: Debt to Equity|PGEN: Total Debt to Equity Ratio|PHAR (Pharming Group) - Debt to Equity|Total Debt to Equity Ratio Nektar Therapeutics Inc|UPB (Upstream Bio Corp) - Total Debt to Equity Ratio|Total Debt to Capital ZBIO|Debt to Equity Immunome, Inc. IMNM|Debt to Equity Ratio gossamerbio.com (GOSS)|KALV: Total Debt to Capital|SEPN - Debt to Capital|Pieris Pharmaceuticals Inc (PVLA) - Total Debt to Equity Ratio|SVRA (Savara Pharma) - Debt to Equity Ratio|RIGL (Rigel Pharmaceuticals) - Debt to Equity Ratio|anaptysbio.com - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio Astria Therapeutics, Inc.|enGene Holdings Inc - Debt to Equity|Aggregate Debt to Equity RAPT|JBIO (aerovatetx.com) - Total Debt to Capital|All Debt to Shareholders' Equity Ratio ACRS (Aclaris Therapeutics)|Total Debt to Capital kyvernatx.com KYTX|TLSA - Total Debt to Capital|Debt to Equity CABA (Cabaletta Bio Inc.)|Ventyx Bio (VTYX) - All Debt to Shareholders' Equity Ratio|Debt to Equity Theratechnologies, Inc|AVTX (Avalo Therapeutics, Inc) - Total Debt to Equity Ratio|Total Debt to Capital eledon.com|Total Debt to Capital AGEN|Total Debt to Capital Climb Bio Inc. CLYM|Total Debt to Equity Ratio ZURA (Zura Bio Limited)|aTyr Pharmaceuticals (ATYR) - Total Debt to Capital|ADAG: Debt to Capital|IMA - Total Debt to Equity Ratio|STTK (shattucklabs.com) - Total Debt to Capital|EQ: Total Debt to Equity Ratio|CNTB (Connect Biopharma Holdings) - Aggregate Debt to Capital|Immunic Inc (IMUX) - Total Debt to Capital|Total Debt to Capital Coefficient ATRA|Total Debt to Capital inflarx.de IFRX|Total Debt to Equity Ratio ACET (Adicet Bio, Inc.)|Total Debt to Capital Celularity Inc CELU|INMB - Total Debt to Capital|BRNS: Debt to Equity|Kezar Life Sciences (KZR) - Debt to Equity|SABS - Debt to Equity|Total Debt to Capital Coefficient AKTX|Total Debt to Equity Ratio ENLV (Enlivex Therapeutics, Ltd.)|Debt to Equity Ratio QTTB|GOVX: Total Debt to Capital|Aggregate Debt to Equity Edesa Biotech, Inc. EDSA|ibioinc.com (IBIO) - Debt to Equity|CARM - Debt to Capital|Debt to Equity XTLB (XTL Biopharmaceuticals Ltd)|boltbio.com (BOLT) - All Debt to Shareholders' Equity Ratio|Debt to Equity HCWB (HCW Biologics)|APVO (Aptevo Therapeutics, Inc.) - Aggregate Debt to Equity|AIM: Total Debt to Capital|All Debt to Shareholders' Equity Ratio ADTX|Total Debt to Capital GRI Bio Inc (GRI)|Total Debt to Capital XORTX XRTX|Debt to Equity HIND|REVB - All Debt to Shareholders' Equity Ratio|indaptusrx.com (INDP) - Debt to Equity|SCNI: Total Debt to Equity Ratio|CalciMedica (CALI) - Total Debt to Capital|Total Debt to Capital AFMD|ALLK: Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio HOOK|Total Debt to Capital igmbio.com|Total Debt to Capital Coefficient iTeos Therapeutics, Inc. ITOS|OCEA - Debt to Equity|TCBP - Total Debt to Equity Ratio|Third Harmonic Bio Inc (THRD) - Debt to Equity